Navigation Links
Biological and Biochemical Product Manufacturing in China Industry Research Report – Now Available from IBISWorld
Date:7/17/2013

San Francisco, CA (PRWEB) July 17, 2013

In the five years to 2013, the Biological and Biochemical Product Manufacturing industry in China has been growing 21.8% per year to total $33.1 billion in 2013, says IBISWorld. The industry has benefited from the rapid development of the national economy, rising household disposable incomes and increasing investment in the healthcare sector by the Chinese government. Improvements in China's social security system, the establishment of a public health system establishment and the formation of the new rural cooperative medical care system have driven up demand for various industry products, particularly vaccines.

The Biological and Biochemical Product Manufacturing industry in China has a low concentration level, with revenue from the top four enterprises – China National Agricultural Development Group, Liaoning Cheng Da, Shenghua Group and Sinopharm – accounting for 19.5% of the total, according to IBISWorld. There are a wide and growing range of industry products and most companies only manufacture one type of product or a few related products, which leads to low market share concentration.

More foreign investment is flooding into the industry due to the favorable conditions it enjoys and its potential for future growth, says IBISWorld. This is leading to increased competition and many domestic enterprises are enlarging their scale, diversifying their product ranges, and working to establish internationally renowned brands. According to China's twelfth five-year plan (2011 to 2015) the government will implement new policies to ensure the industry develops in line with international standards.

For more information, visit IBISWorld’s Biological and Biochemical Product Manufacturing in China industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Industry Report Key Topics

The Biological and Biochemical Product Manufacturing industry manufactures biological and biochemical products and genetically engineered drugs such as vaccines, blood products, and diagnostic reagents.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/china/biological-product-mfg/prweb10922531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Statement from the Sensory Processing Disorder Foundation Endorsing New Breakthrough Study Revealing Biological Basis for Sensory Processing Disorders in Kids
2. Silk and cellulose biologically effective for use in stem cell cartilage repair
3. Men Biologically Programmed to Steer Clear of Friends Wives
4. Dog Study Raises Prospect of Biological Pacemaker for Humans
5. Medicines quality workshop to address standards for microbiological contamination, bioburden control
6. Dr. Daniel Strader of Dallas Designer Smiles Receives Top Reviews as Local Dallas, TX Dentist for Biological Dentistry
7. Researchers discover biological diversity in triple-negative breast cancer
8. Mayo Clinic-led study unravels biological pathway that controls the leakiness of blood vessels
9. Ordinary heart cells become biological pacemakers with injection of a single gene
10. Solving a biological mystery
11. New study pinpoints biochemical mechanism underlying fibrosis following glaucoma surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... Berkeley, and other leading institutions in announcing the launch of the Leadership ... the way animals are raised for food. , Founding members of the Leadership ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
Breaking Medicine Technology: